A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients

This publication has 81 references indexed in Scilit:

• Hemodynamic effects of lisinopril after long-term administration in congestive heart failure
  The American Journal of Cardiology, 1989
• Modulation of hemodynamic effects with a converting enzyme inhibitor: Acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses
  American Heart Journal, 1988
• Acute hemodynamic and hormonal effects of ramipril in chronic congestive heart failure and comparison with captopril
  The American Journal of Cardiology, 1987
• Comparative hemodynamic and clinical effects of long-term treatment with prazosin and captopril for severe chronic congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy
  The American Journal of Cardiology, 1986
• Enalapril in congestive heart failure: acute and chronic invasive hemodynamic evaluation
  International Journal of Cardiology, 1986
• A cooperative multicenter study of captopril in congestive heart failure: Hemodynamic effects and long-term response
  American Heart Journal, 1985
• Clinical and hemodynamic experience with enalapril in congestive heart failure
  The American Journal of Cardiology, 1985
• Hemodynamic effects of captopril in patients with severe chronic heart failure
  The American Journal of Cardiology, 1982
• Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
  Circulation, 1980
• Renin, aldosterone and cardiac decompensation: Studies with an oral converting enzyme inhibitor in heart failure
  The American Journal of Cardiology, 1979